Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy

<p>Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in the young. Acute myocardial ischaemia (a sudden myocardial blood supply/demand mismatch) and pre-existing chronic ionic remodelling (which causes slowed cellular repolarisation) are acknowledged as two key contr...

Descripció completa

Dades bibliogràfiques
Autor principal:	Coleman, JA
Altres autors:	Bueno Orovio, A
Format:	Thesis
Idioma:	English
Publicat:	2024
Matèries:	Computer simulation

Ítems similars

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
per: Coleman, J
Publicat: (2024)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
per: Coleman, JA, et al.
Publicat: (2023)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
per: Chow, J, et al.
Publicat: (2024)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
per: Ji-Jian Chow, et al.
Publicat: (2024-08-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
per: James A. Coleman, et al.
Publicat: (2024-04-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
per: Coleman, JA, et al.
Publicat: (2024)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
per: Coleman, J, et al.
Publicat: (2023)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
per: Zakariye Ashkir, MD, et al.
Publicat: (2024-01-01)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
per: George Joy, MD, et al.
Publicat: (2024-01-01)

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
per: Lyon, A, et al.
Publicat: (2018)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
per: Passini, E, et al.
Publicat: (2015)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
per: Safa Daghem, et al.
Publicat: (2024-01-01)

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study
per: Coleman, JA, et al.
Publicat: (2024)

Atypical ECG Presentation of Hypertrophic Cardiomyopathy stimulating Acute Myocardial Infarction
per: Rikesh Tamrakar
Publicat: (2021-04-01)

Functional assessment of myocardial ischaemia by intracoronary ECG
per: Christian Seiler, et al.
Publicat: (2021-02-01)

Pseudo-arrhythmic ECG artifact
per: Satyajeet Singh, et al.
Publicat: (2012-01-01)

Myocardial Fibrosis in the Pathogenesis, Diagnosis, and Treatment of Hypertrophic Cardiomyopathy
per: Zeyi Cheng, et al.
Publicat: (2021-04-01)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
per: Raman, B, et al.
Publicat: (2017)

Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
per: Yan Dong, et al.
Publicat: (2024-05-01)

Myocardial dysfunction in hypertrophic cardiomyopathy.
per: Ashrafian, H, et al.
Publicat: (2001)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
per: Raman, B, et al.
Publicat: (2018)

Computational detection of electrophysiological abnormalities in hypertrophic cardiomyopathy for risk stratification
per: Lyon, A
Publicat: (2017)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy
per: Raffaele Coppini, MD, PhD, et al.
Publicat: (2019-11-01)

ECG diagnosis of acute ischaemia and infarction: past, present and future.
per: Herring, N, et al.
Publicat: (2006)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
per: Kramer, CM, et al.
Publicat: (2018)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
per: Doste, R, et al.
Publicat: (2022)

Diagnosis and Clinical Implication of Left Ventricular Aneurysm in Hypertrophic Cardiomyopathy
per: Errico Federico Perillo, et al.
Publicat: (2023-05-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
per: S. M. Komissarova, et al.
Publicat: (2021-05-01)

Insights into mechanisms and clinical implications of myocardial fibrosis and its progression in hypertrophic cardiomyopathy
per: Raman, B
Publicat: (2019)

Progression of myocardial dysfunction and prediction of arrhythmic events in patients with exercise-induced arrhythmogenic cardiomyopathy
per: Linda T. Aaserud, MD, et al.
Publicat: (2024-10-01)

Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
per: Pal, N
Publicat: (2015)

HYPERTROPHIC CARDIOMYOPATHY AND MYOCARDIAL CRYPT OF THE LEFT VENTRICLE
per: Yu. V. Frolova, et al.
Publicat: (2017-02-01)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
per: Dai Qinyi, et al.
Publicat: (2010-11-01)

Clasification Of Arrhythmic ECG Data Using Machine Learning Techniques
per: Abhinav Vishwa, et al.
Publicat: (2011-12-01)

Diagnosis and Treatment of Obstructive Hypertrophic Cardiomyopathy
per: Gaetano Todde, et al.
Publicat: (2023-05-01)

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
per: Litt MJ, et al.
Publicat: (2023-04-01)

Application of cardiac electrophysiology simulations to pro−arrhythmic safety testing
per: Mirams, G, et al.
Publicat: (2012)

Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing.
per: Mirams, G, et al.
Publicat: (2012)

Electrophysiological and anatomical factors determine arrhythmic risk in acute myocardial ischemia and its modulation by sodium current availability
per: Martinez-Navarro, H, et al.
Publicat: (2020)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
per: Ashrafian, H, et al.
Publicat: (2003)